Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Stroke. 2010 Apr 15;41(6):1213–1221. doi: 10.1161/STROKEAHA.109.570077

Figure 3.

Figure 3

Primary outcome measures in donepezil and placebo patients. A, V-ADAS-cog least-squares (LS) mean change from baseline; B, CIBIC-Plus overall change at end point. C, V-ADAS-cog LS mean change from baseline for patients with Scheltens’ score <2. D, V-ADAS-cog LS mean change from baseline for patients with Scheltens’ score ≥2. CMH indicates Cochran-Mantel-Haenszel; LOCF, last observation carried forward.